47 related articles for article (PubMed ID: 28802662)
1. The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system.
Yang C; Cheng H; Luo G; Lu Y; Guo M; Jin K; Wang Z; Yu X; Liu C
Eur J Surg Oncol; 2017 Nov; 43(11):2112-2118. PubMed ID: 28802662
[TBL] [Abstract][Full Text] [Related]
2. Association of Cancer Antigen 125 with Long-Term Prognosis in Light-Chain Cardiorenal Amyloidosis.
Wu B; Shi J; Yu F; Wu Y; Tao X; Xuan T; Yang J; Wang X
Cardiorenal Med; 2023; 13(1):19-25. PubMed ID: 36215974
[TBL] [Abstract][Full Text] [Related]
3. Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis.
Karneris A; Dedeilia A; Boland GM
Ann Surg Oncol; 2024 Jan; 31(1):16-18. PubMed ID: 37814185
[No Abstract] [Full Text] [Related]
4. Are Circulating Immune Cells a Determinant of Pancreatic Cancer Risk? A Prospective Study Using Epigenetic Cell Count Measures.
Katzke VA; Le Cornet C; Mahfouz R; Brauer B; Johnson T; Canzian F; Rebours V; Boutron-Ruault MC; Severi G; Schulze MB; Olsen A; Tjønneland A; Overvad K; Crous-Bou M; Molina-Montes E; Amiano P; Huerta JM; Ardanaz E; Perez-Cornago A; Masala G; Pala V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita B; Vermeulen R; Sund M; Franklin O; Christakoudi S; Dossus L; Weiderpass E; Olek S; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2179-2187. PubMed ID: 34548327
[TBL] [Abstract][Full Text] [Related]
5. Correction to: Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genes.
Xu D; Wang Y; Chen Y; Zheng J
Cancer Immunol Immunother; 2023 Mar; 72(3):665. PubMed ID: 36138159
[No Abstract] [Full Text] [Related]
6. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
7. Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma.
Yang C; Cheng H; Zhang Y; Fan K; Luo G; Fan Z; Huang Q; Lu Y; Jin K; Wang Z; Yu X; Liu C
Cancer Immunol Immunother; 2018 Dec; 67(12):1815-1823. PubMed ID: 30167864
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of CD4
Xu J; Jiang L; Cao H; Jia Y; Wu S; Jiang C; Sun T
J Interferon Cytokine Res; 2018 May; 38(5):213-220. PubMed ID: 29664688
[TBL] [Abstract][Full Text] [Related]
10. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
Wang K; Shen T; Siegal GP; Wei S
Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
[TBL] [Abstract][Full Text] [Related]
11. Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.
Håkansson A; Gustafsson B; Krysander L; Håkansson L
Br J Cancer; 1996 Sep; 74(5):670-6. PubMed ID: 8845294
[TBL] [Abstract][Full Text] [Related]
12. CD4 levels and NSCLC metastasis: the benefits of maintaining moderate levels.
Bai Y; Liu Y; Wu J; Miao R; Xu Z; Hu C; Zhou J; Guo J; Xie J; Shi Z; Ding X; Xing Y; Hu D
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16827-16836. PubMed ID: 37733240
[TBL] [Abstract][Full Text] [Related]
13. Low Pretreatment CD4
Turner RJ; Guy TV; Geraghty NJ; Splitt A; Watson D; Brungs D; Carolan MG; Miller AA; de Leon JF; Aghmesheh M; Sluyter R
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628721
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and Prognostic Performance of MicroRNA-25, Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 125 in Pancreatic Ductal Adenocarcinoma.
Gong Y; Song L; Ou L; Lu YY; Huang X; Zeng Q
Iran J Med Sci; 2023 Jul; 48(4):401-413. PubMed ID: 37456201
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte subset is more suitable than systemic inflammatory response biomarker and immunoglobulin in constructing prognostic nomogram model for advanced gastric cancer.
Fang T; Yin X; Wang Y; Zhang L; Wang Y; Zhang X; Zhao X; Lin X; Xue Y
Heliyon; 2023 Mar; 9(3):e14669. PubMed ID: 36994403
[TBL] [Abstract][Full Text] [Related]
16. Mucins as Potential Biomarkers for Early Detection of Cancer.
Gautam SK; Khan P; Natarajan G; Atri P; Aithal A; Ganti AK; Batra SK; Nasser MW; Jain M
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980526
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of standard versus extended lymphadenectomy in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: A Chinese multi-center prospective randomized controlled trial.
Wang W; Lou W; Xu Z; Chen H; Shen Z; Deng X; Peng C; Liu Y; Shen B
J Adv Res; 2023 Jul; 49():151-157. PubMed ID: 36198383
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Circulating Lymphocyte Subsets Before Treatment in Patients with Nasopharyngeal Carcinoma.
Shen DS; Yan C; Liang Y; Chen KH; Zhu XD
Cancer Manag Res; 2021; 13():8109-8120. PubMed ID: 34737639
[TBL] [Abstract][Full Text] [Related]
19. A nomogram of preoperative predictors for occult metastasis in patients with PDAC during laparoscopic exploration.
Ge J; Li L; Ma Z; Jiang B; Yuan C; Wang H; Peng Y; Xiu D
Gland Surg; 2021 Jan; 10(1):279-289. PubMed ID: 33633984
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
